Catalysts About Caris Life Sciences Caris Life Sciences is a precision medicine company focused on whole exome, whole transcriptome and whole genome sequencing across tissue and blood to inform cancer therapy selection, monitoring and early detection. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About Caris Life Sciences Caris Life Sciences is a precision medicine company that leverages Whole Exome, Whole Transcriptome and whole genome sequencing, cloud computing and AI to transform cancer diagnostics, treatment selection and prevention. What are the underlying business or industry changes driving this perspective?Read more
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company’s molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company has a partnership with Everly Health, Inc. for the development of Caris Detect, a Multi-Cancer Early Detection (MCED) blood-based screening assay. The company was founded in 2008 and is headquartered in Irving, Texas.
